Understanding the antiestrogenic actions of raloxifene and a mechanism of drug resistance to tamoxifen
Authors:
- 1 April 1998
- journal article
- review article
- Published by Springer Nature in Breast Cancer
- Vol. 5 (2) , 99-106
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A realistic clinical perspective of tamoxifen and endometrial carcinogenesisEuropean Journal of Cancer, 1996
- A current view of tamoxifen for the treatment and prevention of breast cancerBritish Journal of Pharmacology, 1993
- Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast CancerNew England Journal of Medicine, 1992
- A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancerBritish Journal of Cancer, 1989
- Effects of anti-estrogens on bone in castrated and intact female ratsBreast Cancer Research and Treatment, 1987
- TAMOXIFEN AND CONTRALATERAL BREAST CANCERThe Lancet, 1985
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- Antagonism of estrogen action with a new benzothiophene derived antiestrogenLife Sciences, 1983
- Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata1976
- 243. Antitumour activity of the antiestrogen ICI 46,474 (Tamoxifen) in the dimethylbenzanthracene (DMBA)—induced rat mammary carcinoma modelJournal of Steroid Biochemistry, 1974